NCT03179904 2026-02-24
TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast Cancer
Mayo Clinic
Phase 2 Active not recruiting
Mayo Clinic
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Seagen Inc.